What it is & primary uses
A turmeric-derived polyphenol studied for inflammatory signaling and joint comfort.
Main benefits
- May support joint comfort
- May influence inflammatory markers
Studied protocols
Research doses are grouped by outcome. They describe study designs—not a personal prescription.
500–1,500 mg/day formulated curcuminoids
- Study duration
- 4–12 weeks in many trials
- Interpretation
- Both lower and higher dose categories showed benefit; formulation and comparator choice materially affect interpretation.
04Food sources & equivalents＋
Can food provide a studied amount?
Turmeric powder contains curcumin, but its concentration varies and formulated supplements can alter absorption substantially.
An ingredient-mass estimate of 500–1,500 mg curcumin at the reported 3.14% average
- How this was estimated
- Turmeric weight = curcumin target ÷ 0.0314.
- Important limitation
- This is not a bioavailability equivalence. Curry powder usually contains less curcumin, and enhanced formulations may produce very different blood exposure from culinary turmeric.
Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.
Source: Measured curcumin content of turmeric powders ↗05How to take it for absorption & tolerance＋
With dietary fat
Curcumin is poorly absorbed in its raw form. Lipid carriers and other enhanced formulations can change exposure far more than milligrams alone suggest.
- Practical approach
- Take with a meal containing fat unless the formulation label specifies otherwise; compare formulation as well as dose.
- Watch for
- Piperine can alter drug metabolism, and enhanced formulations may increase both exposure and interaction risk.
Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.
Source: Curcumin formulations and bioavailability review ↗06Supplement interaction check＋
An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.
This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.
07Research notes＋
Moderate for short-term knee-osteoarthritis pain and function, but formulation-dependent absorption prevents simple milligram equivalence.
Bioavailability differs substantially by formulation, so raw milligram comparisons can be misleading.
08Scientific references＋
Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.
Curcuma longa/curcumin for osteoarthritis
Dose context: Multiple extracts and formulations
Improved pain, function and stiffness versus placebo, with evidence-quality and formulation limitations.
High- versus low-dose curcumin in knee osteoarthritis
Dose context: <1,000 mg/day versus ≥1,000 mg/day
No significant difference between dose categories for pain relief or adverse events.
Curcumin formulations in osteoarthritis
Dose context: Multiple enhanced and conventional formulations
Potential symptom benefit remains plausible, but major formulation heterogeneity and limited review quality prevent simple dose equivalence.
09Expert & media references＋
Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.